Avalon Pharmaceuticals Company Profile

10:52 EDT 23rd September 2017 | BioPortfolio

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon is able to pinpoint proprietary drug activity markers and drug targets and to use these for drug screening in complex biological systems, facilitating the identification of lead drug candidates. Avalon is developing these drug candidates both internally and through partnerships within the pharmaceutical industry.

By attracting a leading team of innovative scientists and drug discovery experts, utilizing cutting-edge genomics tools, and forming strategic alliances within the industry, Avalon is significantly decreasing the time it takes to develop novel drug therapies to treat deseases. Within the Company's first two-years, Avalon scientists were able to use their novel genomic discovery and screening approaches to identify several small molecule drug candidates for the treatment of cancer.

Avalon identifies small molecule therapeutic compounds directly from genomics data in three steps:

Identification of novel and key proprietary drug activity markers using a comprehensive set of genomics tools including molecular and pathological characterization, cytogenetics, and high density gene expression arrays,

Screening for new small molecule therapeutic compounds using its proprietary methods such as the Company's multi-parameter assays, and

Optimization of lead compounds using cutting-edge medicinal chemistry.

The company's initial therapeutic focus area is solid tumors including cancers of colon, breast, lung, and prostate.

Avalon's strategy of combining the latest genomic approaches for gene and target identification with an aggressive pursuit of small molecule drug discovery has attracted significant interest from the pharmaceutical industry. In order to quickly pursue large-scale discovery and drug development within particular disease areas, Avalon enters partnerships with pharmaceutical companies as well as collaborative agreements with clinical and academic institutions.


20358 Seneca Meadows Parkway
United States of America


Phone: 301-556-1000
Fax: 301-556-1100

News Articles [1243 Associated News Articles listed on BioPortfolio]

Avalon Healthcare Solutions Names Chief Growth Officer and Chief Operating Officer

TAMPA, Fla., June 28, 2017 /PRNewswire/ -- Avalon Healthcare Solutions, the leader in technology-enabled laboratory benefit management, today announced the appointment of two senior executives. Barry ...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Avalon GloboCare Corp. Completes Acquisition of Executive Center Property in Freehold, New Jersey

FREEHOLD, NJ -- (Marketwired) -- 05/09/17 -- Avalon GloboCare Corp. (OTCQB: AVCO) (, an intelligent cell-based biotechnology developer and healthcare service provider, announ...

Syndax Pharmaceuticals to Present at Upcoming Fall Conferences

WALTHAM, Mass., Oct. 24, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a late-stage epigenetics oncology company, announced today that members of management will present at the following upcoming...

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has receiv...

Ritter Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

LOS ANGELES, CA -- (Marketwired) -- 08/07/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a leading developer of novel therapeutic products that modu...

Earnings Preview: Valeant Pharmaceuticals

The week of May 8 is big for generic drug companies . Valeant Pharmaceuticals , Mylan , Endo International , and Teva Pharmaceuticals all report results this week.

PubMed Articles [158 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [199 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1282 Associated Companies listed on BioPortfolio]

Avalon Pharmaceuticals

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon i...

Avalon Instruments

The Avalon's range of Raman Analyzers offer you High Performance Raman Spectoscopy. Our cutting edge detection, sampling technology, automated calibration and pinned-in-place optics coupled with our i...

Avalon Network NV

Avalon Network helps you to realise re-engineering benefits trough information technology. Our multi-level approach makes our projects Human-centered Result-oriented Technologically reliable We team u...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Avalon Pharmaceuticals" on BioPortfolio

We have published hundreds of Avalon Pharmaceuticals news stories on BioPortfolio along with dozens of Avalon Pharmaceuticals Clinical Trials and PubMed Articles about Avalon Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avalon Pharmaceuticals Companies in our database. You can also find out about relevant Avalon Pharmaceuticals Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record